| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 02/26/2004 | WO2004016583A1 Substituted glycine derivatives for use as medicaments |
| 02/26/2004 | WO2004016580A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 02/26/2004 | WO2004016579A1 Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters |
| 02/26/2004 | WO2004016260A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | US20040039228 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature |
| 02/26/2004 | US20040039223 Cis and trans configurations of these chemical intermediates for insecticides, miticides, and herbicides or drugs; prepared using water as solvent to form a hydrolyzable spirohydantoin from a 4-alkylcyclohexanone |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
| 02/26/2004 | DE20215415U1 Wasserlösliche Medikamentenvorstufen von Propofol Water-soluble prodrugs of propofol |
| 02/26/2004 | DE10237285A1 Production of 3-amino-4,4,4-trifluorocrotonate ester for use in synthesis of plant protection agents involves reacting alkyl trifluoroacetate with alkyl acetate and metal alcoholate to form an enolate which is then reacted with amine |
| 02/26/2004 | CA2497347A1 R(+)-2-amino-3-hydroxypropanoic acid derivatives with glycinergic action |
| 02/26/2004 | CA2494811A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 02/26/2004 | CA2494546A1 Substituted glycine derivatives for use as medicaments |
| 02/25/2004 | EP1391449A1 Hydrolysis of amino acid diesters |
| 02/25/2004 | EP1391448A1 Optically active diamines and their use in catalytic processes |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1390341A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390337A1 Precursors for ketones and aldehydes |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP0990639B1 Process for producing n-cyclopropylanilines and intermediates used therefor |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1477097A Preparation method of 2-amino-5-fluorobenzoic acid |
| 02/25/2004 | CN1477096A Methof for preparing l-valine and d-valine by using chemical resolution process |
| 02/25/2004 | CN1477095A Production method of N-benzyl glycine ethyl ester |
| 02/25/2004 | CN1139571C Process for preparing homophenylalanin derivs |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/24/2004 | US6696600 L-DOPA ethyl ester salts and uses thereof |
| 02/24/2004 | US6696489 Phenolic and phenylamino substituents; beta 3-adrenoceptor agonists; obesity, hyperglycemia, intestinal hypermotility, pollakiuria, urinary incontinence, depression |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/19/2004 | WO2004014682A1 A vehicle and a vehicle door |
| 02/19/2004 | WO2004014550A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 02/19/2004 | US20040034248 Subjecting cyclohexanediacetic acid-amide to Hofmann reaction forming solution comprising isocyanate intermediate, hydrolyzing intermediate, forming amine salt in solvent, then adding/removing ion exhchange resin to concentrate |
| 02/19/2004 | US20040034246 Radiofluorinated imaging agents which are utilzed in Positron Emission Tomography for diagonsis of Parkinson's disease |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034091 Derivative of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/18/2004 | EP1208078B1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
| 02/18/2004 | CN1476426A Dimethy/amine/ester adducts and their use in polymerizable compositions |
| 02/18/2004 | CN1138768C Method for preparation of citalopram |
| 02/18/2004 | CN1138766C Processes for preparation of oxo-oxazoline or alloamino acid derivatives |
| 02/18/2004 | CN1138755C Cyclic amino acids and derivs thereof useful as pharmaceutical agents |
| 02/17/2004 | US6693215 Process for the preparation of salts of L-carnitine and alkanoyl L-carnitine with mucic acid |
| 02/17/2004 | US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 02/17/2004 | CA2292334C A process for production of amino acid hydrochloride and caustic via electrodialysis water splitting |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |
| 02/12/2004 | WO2004013086A1 Photoactive materials |
| 02/12/2004 | WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | WO2004013084A1 Sphingosinoids and external preparations for skin containing the same |
| 02/12/2004 | WO2003097582A3 Synthesis of benzonitriles and benzimidates |
| 02/12/2004 | US20040030177 Without use of enzymes; deesterification in presence of sodium acetate |
| 02/12/2004 | US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 02/12/2004 | DE10320211A1 Enantiomerically enriched beta-amino acid preparation, for use e.g. as drug intermediate, comprises selective enzymatic hydrolysis of new or known racemic beta-aminoacid ester other than the methyl or ethyl ester |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1165491B1 Lta4 hydrolase inhibitors |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1473816A Process for preparing amino-acid chelated iron by hydrolyzing keratin |
| 02/11/2004 | CN1137877C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in in urinary lithasis |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689905 Reacting 2,6-dimethyl-3-oxo-bicyclo(2.2.1)heptane-1-carboxylic acid, separating the diastereomers using reversed phase chromatography |
| 02/10/2004 | US6689904 Psychological disorders; cognition activators; resolution, separation of mixtures |
| 02/10/2004 | US6689899 Diamine and acid anhydride |
| 02/10/2004 | US6689753 Alzheimer inhibitor peptide ia beta 5 (amino acid sequence 1leu-pro-phe-phe-asp) analog |
| 02/10/2004 | CA2164951C Lipoxin compounds |
| 02/05/2004 | WO2004011414A1 E-ISOMERIC β-AROMATIC OR HETEROAROMATIC SUBSTITUTED β-ACYLAMINO-ACRYLATES AND METHODS OF PREPARING THE SAME |
| 02/05/2004 | US20040024252 By reacting suitable amine acid compound with organic acid; for protecting organic materials, in particular synthetic polymers, reprographic materials or coating materials against oxidative, thermal or light-induced degradation |
| 02/05/2004 | US20040024229 Production method for biarylalanine |
| 02/05/2004 | US20040024224 Synthesis of 2-alkyl amino acids |
| 02/05/2004 | US20040024150 Amino acid complexes and the use thereof in producing olefin polymers |
| 02/05/2004 | US20040024061 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040023344 Method for producing an optically activ beta-amino acid |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040021132 Adding organic complexing agent to first aqueous solution of actinide An1 in oxidation state (IV) in order to form complex; adding complexing agent to second aqueous solution of an actinide An2 in oxidation state (IV); mixing; precipitation |
| 02/04/2004 | EP1386910A1 Photoactive materials |
| 02/04/2004 | EP1386901A1 Method for producing an optically active beta-amino acid |
| 02/04/2004 | EP1385821A2 Novel anti-adhesive compounds and uses thereof |
| 02/04/2004 | EP0983264B1 Method of manufacturing sertindole |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1472194A Production and use of optical N-acylalanine bactericides |
| 02/04/2004 | CN1137088C Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 02/04/2004 | CN1137087C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/03/2004 | US6686499 By reacting the benzoic acid is 2,3,4,-trifluorobenzoic acid and the aniline 2-chloro-4-iodoaniline in lithium hexamethyldisilazide |
| 02/03/2004 | US6686479 Separation of enantiomorphs |
| 02/03/2004 | US6686441 Comonomer compositions for production of imide-containing polyamino acids |
| 02/03/2004 | US6686440 Copolymerizing aspartic acid and succinimides with heat; antiscaling agents; cosmetics, cements; superabsorbence; liquid laundery detergents; disposable diapers |
| 02/03/2004 | CA2084109C Novel process for preparing 4-amino-5-hexanoic acid |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009034A2 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |